๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT ยท Real-Time Price ยท USD
2.980
+0.070 (2.41%)
Nov 18, 2026, 4:00 PM EST - Market closed

Galectin Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-14.79-20.09-42.43-38.07-38.35-30.18
Net Income
-23.37-30.97-47.2-44.81-38.87-30.7
Earnings Per Share
-0.33-0.48-0.76-0.74-0.65-0.52
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11.7117.7215.1225.6618.5939.65
Total Debt
38.85137.72106.6672.8139.9329.06
Net Cash (Debt)
-27.15-120-91.54-47.15-21.3410.59
Net Cash Growth
------60.90%
Net Cash Per Share
-0.38-1.88-1.47-0.78-0.360.18

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.61-23.88-41.77-32.97-31.06-24.31
Free Cash Flow
-14.61-23.88-41.77-32.97-31.06-24.31
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.